ID   RDRP_BPQBE              Reviewed;         589 AA.
AC   P14647; Q8LTE0;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   22-JUL-2015, entry version 61.
DE   RecName: Full=RNA-directed RNA polymerase subunit beta;
DE            EC=2.7.7.48;
DE   AltName: Full=RNA replicase beta chain;
DE   AltName: Full=RNA-directed RNA polymerase subunit II {ECO:0000303|PubMed:816798};
OS   Enterobacteria phage Qbeta (Bacteriophage Q-beta).
OC   Viruses; ssRNA viruses; ssRNA positive-strand viruses, no DNA stage;
OC   Leviviridae; Allolevivirus.
OX   NCBI_TaxID=39803;
OH   NCBI_TaxID=562; Escherichia coli.
RN   [1]
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=2538637; DOI=10.1016/0022-2836(89)90319-7;
RA   Mills D.R., Priano C., Dimauro P., Binderow B.D.;
RT   "Q-beta replicase: mapping the functional domains of an RNA-dependent
RT   RNA polymerase.";
RL   J. Mol. Biol. 205:751-764(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE.
RA   Mekler P.;
RL   Thesis (1981), University of Zurich, Switzerland.
RN   [3]
RP   NUCLEOTIDE SEQUENCE, AND VARIANT ILE-198.
RX   PubMed=14667253; DOI=10.1186/1471-2148-3-24;
RA   Bacher J.M., Bull J.J., Ellington A.D.;
RT   "Evolution of phage with chemically ambiguous proteomes.";
RL   BMC Evol. Biol. 3:24-24(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ILE-198.
RC   STRAIN=Anc(P1);
RX   PubMed=25056887; DOI=10.1128/JVI.01127-14;
RA   Kashiwagi A., Sugawara R., Sano-Tsushima F., Kumagai T., Yomo T.;
RT   "Contribution of silent mutations to thermal adaptation of RNA
RT   bacteriophage Qbeta.";
RL   J. Virol. 88:11459-11468(2014).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA] OF 1-23.
RX   PubMed=1247542; DOI=10.1016/0005-2787(76)90067-8;
RA   Weber H.;
RT   "The binding site for coat protein on bacteriophage Q-beta RNA.";
RL   Biochim. Biophys. Acta 418:175-183(1976).
RN   [6]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=816798;
RA   Carmichael G.G., Landers T.A., Weber K.;
RT   "Immunochemical analysis of the functions of the subunits of phage
RT   Qbeta ribonucleic acid replicase.";
RL   J. Biol. Chem. 251:2744-2748(1976).
RN   [7]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=6358207;
RA   Guerrier-Takada C., Subramanian A.R., Cole P.E.;
RT   "The activity of discrete fragments of ribosomal protein S1 in Q beta
RT   replicase function.";
RL   J. Biol. Chem. 258:13649-13652(1983).
RN   [8]
RP   CONSTRUCT TO PRODUCE VIRAL CATALYTIC CORE.
RX   PubMed=16781472; DOI=10.1263/jbb.101.421;
RA   Kita H., Cho J., Matsuura T., Nakaishi T., Taniguchi I., Ichikawa T.,
RA   Shima Y., Urabe I., Yomo T.;
RT   "Functional Qbeta replicase genetically fusing essential subunits EF-
RT   Ts and EF-Tu with beta-subunit.";
RL   J. Biosci. Bioeng. 101:421-426(2006).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF VIRAL CATALYTIC CORE,
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=20534494; DOI=10.1073/pnas.1003015107;
RA   Kidmose R.T., Vasiliev N.N., Chetverin A.B., Andersen G.R.,
RA   Knudsen C.R.;
RT   "Structure of the Qbeta replicase, an RNA-dependent RNA polymerase
RT   consisting of viral and host proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:10884-10889(2010).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF VIRAL CATALYTIC CORE IN
RP   COMPLEX WITH CALCIUM, FUNCTION, COFACTOR, SUBUNIT, AND MUTAGENESIS OF
RP   LYS-78; ARG-153; ARG-164; LYS-214; ARG-220; ASP-274; SER-279; TYR-357;
RP   ASP-359; ASP-360; GLU-395; TYR-411 AND ARG-413.
RX   PubMed=20798060; DOI=10.1073/pnas.1006559107;
RA   Takeshita D., Tomita K.;
RT   "Assembly of Q{beta} viral RNA polymerase with host translational
RT   elongation factors EF-Tu and -Ts.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:15733-15738(2010).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.41 ANGSTROMS) OF VIRAL CATALYTIC CORE IN
RP   COMPLEX WITH CALCIUM, FUNCTION, COFACTOR, SUBUNIT, AND MUTAGENESIS OF
RP   HIS-168; ARG-241; PHE-329; TYR-357; TYR-511 AND ASN-549.
RX   PubMed=22245970; DOI=10.1038/nsmb.2204;
RA   Takeshita D., Tomita K.;
RT   "Molecular basis for RNA polymerization by Qbeta replicase.";
RL   Nat. Struct. Mol. Biol. 19:229-237(2012).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF VIRAL CATALYTIC CORE IN
RP   COMPLEX WITH CALCIUM, FUNCTION, COFACTOR, AND SUBUNIT.
RX   PubMed=22884418; DOI=10.1016/j.str.2012.07.004;
RA   Takeshita D., Yamashita S., Tomita K.;
RT   "Mechanism for template-independent terminal adenylation activity of
RT   Qbeta replicase.";
RL   Structure 20:1661-1669(2012).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) OF 2-589 OF REPLICASE,
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=25122749; DOI=10.1093/nar/gku745;
RA   Takeshita D., Yamashita S., Tomita K.;
RT   "Molecular insights into replication initiation by Qbeta replicase
RT   using ribosomal protein S1.";
RL   Nucleic Acids Res. 42:10809-10822(2014).
CC   -!- FUNCTION: This is the catalytic subunit of the viral RNA-dependent
CC       RNA polymerase complex. {ECO:0000269|PubMed:20534494,
CC       ECO:0000269|PubMed:20798060, ECO:0000269|PubMed:22245970,
CC       ECO:0000269|PubMed:22884418, ECO:0000269|PubMed:25122749,
CC       ECO:0000269|PubMed:6358207, ECO:0000269|PubMed:816798}.
CC   -!- CATALYTIC ACTIVITY: Nucleoside triphosphate + RNA(n) = diphosphate
CC       + RNA(n+1). {ECO:0000255|PROSITE-ProRule:PRU00539}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:20798060,
CC         ECO:0000269|PubMed:22245970, ECO:0000269|PubMed:22884418};
CC       Note=Binds 2 Mg(2+) per subunit, Ca(2+) is used in crystallization
CC       to prevent RNA polymerase activity. {ECO:0000269|PubMed:20798060,
CC       ECO:0000269|PubMed:22245970, ECO:0000269|PubMed:22884418,
CC       ECO:0000305|PubMed:22884418};
CC   -!- SUBUNIT: Part of the viral RNA-dependent RNA polymerase complex,
CC       the other subunits are the host ribosomal protein S1, EF-Tu and
CC       EF-Ts. {ECO:0000269|PubMed:20534494, ECO:0000269|PubMed:20798060,
CC       ECO:0000269|PubMed:22245970, ECO:0000269|PubMed:22884418,
CC       ECO:0000269|PubMed:25122749, ECO:0000269|PubMed:6358207,
CC       ECO:0000269|PubMed:816798}.
CC   -!- MISCELLANEOUS: In order to produce high amounts of RNA polymerase
CC       catalytic core, a fusion protein consisting of tsf-tufB-replicase
CC       with a cleavable linker between tufB and the viral replicase
CC       subunit is frequently used. {ECO:0000269|PubMed:16781472,
CC       ECO:0000269|PubMed:20798060, ECO:0000269|PubMed:22245970,
CC       ECO:0000269|PubMed:22884418, ECO:0000269|PubMed:25122749}.
CC   -!- SIMILARITY: Contains 1 RdRp catalytic domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00539}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X14764; CAA32872.1; -; mRNA.
DR   EMBL; AY099114; AAM33128.1; -; Genomic_RNA.
DR   EMBL; AB971354; BAP18765.1; -; Genomic_RNA.
DR   EMBL; M24876; AAA50307.1; -; Genomic_RNA.
DR   PIR; S03340; RRBPBQ.
DR   PDB; 3AGP; X-ray; 2.80 A; A=1-589.
DR   PDB; 3AGQ; X-ray; 3.22 A; A=1-589.
DR   PDB; 3AVT; X-ray; 2.61 A; A=1-589.
DR   PDB; 3AVU; X-ray; 2.91 A; A=1-589.
DR   PDB; 3AVV; X-ray; 3.12 A; A=1-589.
DR   PDB; 3AVW; X-ray; 2.60 A; A=1-589.
DR   PDB; 3AVX; X-ray; 2.41 A; A=1-589.
DR   PDB; 3AVY; X-ray; 2.62 A; A=1-589.
DR   PDB; 3MMP; X-ray; 2.50 A; F/G=1-589.
DR   PDB; 3VNU; X-ray; 3.20 A; A=1-589.
DR   PDB; 3VNV; X-ray; 2.60 A; A=1-589.
DR   PDB; 4FWT; X-ray; 3.20 A; A=1-589.
DR   PDB; 4Q7J; X-ray; 2.90 A; C/G=2-589.
DR   PDBsum; 3AGP; -.
DR   PDBsum; 3AGQ; -.
DR   PDBsum; 3AVT; -.
DR   PDBsum; 3AVU; -.
DR   PDBsum; 3AVV; -.
DR   PDBsum; 3AVW; -.
DR   PDBsum; 3AVX; -.
DR   PDBsum; 3AVY; -.
DR   PDBsum; 3MMP; -.
DR   PDBsum; 3VNU; -.
DR   PDBsum; 3VNV; -.
DR   PDBsum; 4FWT; -.
DR   PDBsum; 4Q7J; -.
DR   Proteomes; UP000001616; Genome.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0003968; F:RNA-directed RNA polymerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0019079; P:viral genome replication; IEA:InterPro.
DR   InterPro; IPR007096; RNA-dir_Rpol_phage_catalytic.
DR   InterPro; IPR005093; RNArep_beta.
DR   Pfam; PF03431; RNA_replicase_B; 1.
DR   PROSITE; PS50522; RDRP_PHAGE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Complete proteome; Metal-binding;
KW   Nucleotide-binding; Nucleotidyltransferase;
KW   RNA-directed RNA polymerase; Transferase; Viral RNA replication.
FT   CHAIN         1    589       RNA-directed RNA polymerase subunit beta.
FT                                /FTId=PRO_0000164855.
FT   DOMAIN      259    391       RdRp catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00539}.
FT   METAL       274    274       Calcium 1. {ECO:0000269|PubMed:20798060,
FT                                ECO:0000269|PubMed:22245970,
FT                                ECO:0000269|PubMed:22884418}.
FT   METAL       274    274       Calcium 2. {ECO:0000269|PubMed:20798060,
FT                                ECO:0000269|PubMed:22245970,
FT                                ECO:0000269|PubMed:22884418}.
FT   METAL       359    359       Calcium 1. {ECO:0000269|PubMed:20798060,
FT                                ECO:0000269|PubMed:22245970,
FT                                ECO:0000269|PubMed:22884418}.
FT   METAL       359    359       Calcium 2. {ECO:0000269|PubMed:20798060,
FT                                ECO:0000269|PubMed:22245970,
FT                                ECO:0000269|PubMed:22884418}.
FT   METAL       360    360       Calcium 1. {ECO:0000269|PubMed:20798060,
FT                                ECO:0000269|PubMed:22245970,
FT                                ECO:0000269|PubMed:22884418}.
FT   METAL       360    360       Calcium 2. {ECO:0000269|PubMed:20798060,
FT                                ECO:0000269|PubMed:22245970,
FT                                ECO:0000269|PubMed:22884418}.
FT   VARIANT     198    198       T -> I. {ECO:0000269|PubMed:14667253,
FT                                ECO:0000269|PubMed:25056887}.
FT   MUTAGEN      78     78       K->A: Loss of RNA polymerase activity.
FT                                {ECO:0000269|PubMed:20798060}.
FT   MUTAGEN     153    153       R->A: Loss of RNA polymerase activity.
FT                                {ECO:0000269|PubMed:20798060}.
FT   MUTAGEN     164    164       R->A: 80% loss of RNA polymerase
FT                                activity. {ECO:0000269|PubMed:20798060}.
FT   MUTAGEN     168    168       H->A: 80% loss of RNA polymerase
FT                                activity. {ECO:0000269|PubMed:22245970}.
FT   MUTAGEN     214    214       K->A: Loss of RNA polymerase activity.
FT                                {ECO:0000269|PubMed:20798060}.
FT   MUTAGEN     220    220       R->A: Loss of RNA polymerase activity.
FT                                {ECO:0000269|PubMed:20798060}.
FT   MUTAGEN     241    241       R->A: Decreased inititation of RNA
FT                                polymerase activity.
FT                                {ECO:0000269|PubMed:22245970}.
FT   MUTAGEN     274    274       D->A: Loss of RNA polymerase activity.
FT                                {ECO:0000269|PubMed:20798060}.
FT   MUTAGEN     279    279       S->A: Loss of RNA polymerase activity.
FT                                {ECO:0000269|PubMed:20798060}.
FT   MUTAGEN     329    329       F->A: Decreased inititation of RNA
FT                                polymerase activity.
FT                                {ECO:0000269|PubMed:22245970}.
FT   MUTAGEN     357    357       Y->A: Decreased inititation of RNA
FT                                polymerase activity.
FT                                {ECO:0000269|PubMed:20798060,
FT                                ECO:0000269|PubMed:22245970}.
FT   MUTAGEN     359    359       D->A: Loss of RNA polymerase activity.
FT                                {ECO:0000269|PubMed:20798060}.
FT   MUTAGEN     360    360       D->A: Loss of RNA polymerase activity.
FT                                {ECO:0000269|PubMed:20798060}.
FT   MUTAGEN     395    395       E->A: Loss of RNA polymerase activity.
FT                                {ECO:0000269|PubMed:20798060}.
FT   MUTAGEN     411    411       Y->A: 60% loss of RNA polymerase
FT                                activity. {ECO:0000269|PubMed:20798060}.
FT   MUTAGEN     413    413       R->A: Loss of RNA polymerase activity.
FT                                {ECO:0000269|PubMed:20798060}.
FT   MUTAGEN     511    511       Y->A: 50% loss of RNA polymerase
FT                                activity. {ECO:0000269|PubMed:22245970}.
FT   MUTAGEN     549    549       N->A: 25% loss of RNA polymerase
FT                                activity. {ECO:0000269|PubMed:22245970}.
FT   MUTAGEN     549    549       N->G: 50% loss of RNA polymerase
FT                                activity. {ECO:0000269|PubMed:22245970}.
FT   HELIX        11     19       {ECO:0000244|PDB:3MMP}.
FT   HELIX        29     40       {ECO:0000244|PDB:3MMP}.
FT   HELIX        49     53       {ECO:0000244|PDB:3MMP}.
FT   HELIX        63     75       {ECO:0000244|PDB:3MMP}.
FT   TURN         76     78       {ECO:0000244|PDB:3MMP}.
FT   HELIX        88    110       {ECO:0000244|PDB:3MMP}.
FT   HELIX       123    139       {ECO:0000244|PDB:3MMP}.
FT   HELIX       145    151       {ECO:0000244|PDB:3MMP}.
FT   HELIX       164    166       {ECO:0000244|PDB:3MMP}.
FT   HELIX       169    174       {ECO:0000244|PDB:3MMP}.
FT   STRAND      177    179       {ECO:0000244|PDB:3MMP}.
FT   HELIX       181    183       {ECO:0000244|PDB:3MMP}.
FT   HELIX       184    192       {ECO:0000244|PDB:3MMP}.
FT   STRAND      200    203       {ECO:0000244|PDB:3MMP}.
FT   STRAND      205    212       {ECO:0000244|PDB:3MMP}.
FT   STRAND      220    224       {ECO:0000244|PDB:3MMP}.
FT   HELIX       227    244       {ECO:0000244|PDB:3MMP}.
FT   HELIX       245    247       {ECO:0000244|PDB:3MMP}.
FT   HELIX       255    267       {ECO:0000244|PDB:3MMP}.
FT   STRAND      270    275       {ECO:0000244|PDB:3MMP}.
FT   HELIX       278    280       {ECO:0000244|PDB:3MMP}.
FT   HELIX       284    290       {ECO:0000244|PDB:3MMP}.
FT   HELIX       293    302       {ECO:0000244|PDB:3MMP}.
FT   STRAND      305    308       {ECO:0000244|PDB:3MMP}.
FT   STRAND      314    316       {ECO:0000244|PDB:3MMP}.
FT   STRAND      318    320       {ECO:0000244|PDB:3MMP}.
FT   HELIX       328    347       {ECO:0000244|PDB:3MMP}.
FT   HELIX       351    353       {ECO:0000244|PDB:3MMP}.
FT   STRAND      355    357       {ECO:0000244|PDB:3MMP}.
FT   STRAND      360    364       {ECO:0000244|PDB:3MMP}.
FT   HELIX       365    367       {ECO:0000244|PDB:3MMP}.
FT   HELIX       368    377       {ECO:0000244|PDB:3MMP}.
FT   HELIX       384    386       {ECO:0000244|PDB:3MMP}.
FT   STRAND      388    396       {ECO:0000244|PDB:3MMP}.
FT   STRAND      399    402       {ECO:0000244|PDB:3MMP}.
FT   HELIX       419    433       {ECO:0000244|PDB:3MMP}.
FT   HELIX       441    451       {ECO:0000244|PDB:3MMP}.
FT   HELIX       456    460       {ECO:0000244|PDB:3MMP}.
FT   STRAND      469    474       {ECO:0000244|PDB:3MMP}.
FT   HELIX       476    478       {ECO:0000244|PDB:3MMP}.
FT   STRAND      483    485       {ECO:0000244|PDB:3MMP}.
FT   STRAND      488    501       {ECO:0000244|PDB:3MMP}.
FT   HELIX       505    517       {ECO:0000244|PDB:3MMP}.
FT   HELIX       536    542       {ECO:0000244|PDB:3MMP}.
FT   STRAND      553    567       {ECO:0000244|PDB:3MMP}.
SQ   SEQUENCE   589 AA;  65518 MW;  20FED8660FE42610 CRC64;
     MSKTASSRNS LSAQLRRAAN TRIEVEGNLA LSIANDLLLA YGQSPFNSEA ECISFSPRFD
     GTPDDFRINY LKAEIMSKYD DFSLGIDTEA VAWEKFLAAE AECALTNARL YRPDYSEDFN
     FSLGESCIHM ARRKIAKLIG DVPSVEGMLR HCRFSGGATT TNNRSYGHPS FKFALPQACT
     PRALKYVLAL RASTHFDTRI SDISPFNKAV TVPKNSKTDR CIAIEPGWNM FFQLGIGGIL
     RDRLRCWGID LNDQTINQRR AHEGSVTNNL ATVDLSAASD SISLALCELL LPPGWFEVLM
     DLRSPKGRLP DGSVVTYEKI SSMGNGYTFE LESLIFASLA RSVCEILDLD SSEVTVYGDD
     IILPSCAVPA LREVFKYVGF TTNTKKTFSE GPFRESCGKH YYSGVDVTPF YIRHRIVSPA
     DLILVLNNLY RWATIDGVWD PRAHSVYLKY RKLLPKQLQR NTIPDGYGDG ALVGSVLINP
     FAKNRGWIRY VPVITDHTRD RERAELGSYL YDLFSRCLSE SNDGLPLRGP SGCDSADLFA
     IDQLICRSNP TKISRSTGKF DIQYIACSSR VLAPYGVFQG TKVASLHEA
//
